https://www.neushen.com/ 2026-02-02 daily 1 https://www.neushen.com/taglist.html 2026-02-02 daily 0.8 https://www.neushen.com/Careers/2.html 2026-02-11 daily 0.6 https://www.neushen.com/Careers/3.html 2026-02-11 daily 0.6 https://www.neushen.com/careers/4.html 2026-02-11 daily 0.6 https://www.neushen.com/careers/7.html 2026-02-06 daily 0.6 https://www.neushen.com/careers.html 2026-02-02 daily 0.6 https://www.neushen.com/news.html 2026-02-02 daily 0.6 https://www.neushen.com/publications.html 2026-02-02 daily 0.6 https://www.neushen.com/our-pipeline.html 2026-02-02 daily 0.6 https://www.neushen.com/company.html 2026-02-02 daily 0.6 https://www.neushen.com/news/2026 2026-01-04 daily 0.6 https://www.neushen.com/careers/6.html 2025-08-01 daily 0.6 https://www.neushen.com/careers/5.html 2025-08-01 daily 0.6 https://www.neushen.com/news/2025.html 2025-06-04 daily 0.6 https://www.neushen.com/news/2022.html 2025-02-18 daily 0.6 https://www.neushen.com/news/2024.html 2025-02-18 daily 0.6 https://www.neushen.com/news/2023.html 2025-02-18 daily 0.6 https://www.neushen.com/Publications/2.html 2025-02-18 daily 0.6 https://www.neushen.com/publications/2023.html 2025-02-18 daily 0.6 https://www.neushen.com/publications/2024.html 2025-02-18 daily 0.6 https://www.neushen.com/news.html 2025-02-08 daily 0.6 https://www.neushen.com/News/2.html 2025-02-08 daily 0.6 https://www.neushen.com/publications.html 2025-02-08 daily 0.6 https://www.neushen.com/company/1821485152824655872.html 2024-08-08 daily 0.6 https://www.neushen.com/company/1974.html 2023-04-20 daily 0.6 https://www.neushen.com/careers/2026/02.html 2026-03-06 daily 0.5 https://www.neushen.com/careers/2025/4.html 2026-03-06 daily 0.5 https://www.neushen.com/careers/2025/01.html 2026-02-11 daily 0.5 https://www.neushen.com/careers/2026/01.html 2026-02-06 daily 0.5 https://www.neushen.com/contact-us.html 2026-02-02 daily 0.5 https://www.neushen.com/therapeutic-areas.html 2026-02-02 daily 0.5 https://www.neushen.com/successfully.html 2026-02-02 daily 0.5 https://www.neushen.com/news/2026/neushen-therapeutics-announces-completion-of-series-a-plus-financing.html 2026-02-02 daily 0.5 https://www.neushen.com/news/2026/ns_136_fda_ind_clearance_aad.html 2026-02-02 daily 0.5 https://www.neushen.com/news/2025/ns_136_phase_2_schizophrenia_first_patient_dosed.html 2026-01-12 daily 0.5 https://www.neushen.com/news/2025/global_biopharma_leadership_forum.html 2026-01-12 daily 0.5 https://www.neushen.com/news/2023/neushen-therapeutics-announces-poster-presentation-of-m4-pam-at-neuroscience.html 2026-01-12 daily 0.5 https://www.neushen.com/news/2022/neushen-therapeutics-closes-pre-a-financing-with-20m.html 2026-01-12 daily 0.5 https://www.neushen.com/news/2022/neushen-announces-upcoming-participation-at-conferences.html 2026-01-12 daily 0.5 https://www.neushen.com/news/2022/donations-rural-china.html 2026-01-12 daily 0.5 https://www.neushen.com/news/2022/dr-joan-shen-named-woman-leader-of-the-year-by-bay-helix.html 2026-01-12 daily 0.5 https://www.neushen.com/news/2023/neushen-therapeutics-funds-als-research-at-umass-chan-medical-school.html 2026-01-12 daily 0.5 https://www.neushen.com/news/2023/neushen-therapeutics-celebrates-r---d-center-opening-in-boston.html 2026-01-12 daily 0.5 https://www.neushen.com/news/2023/neushen-therapeutics-announces-license-agreement-with-hangzhou-healzen-therapeutics.html 2026-01-12 daily 0.5 https://www.neushen.com/news/2023/neushen-therapeutics-activities-bio-international-convention.html 2026-01-12 daily 0.5 https://www.neushen.com/news/2023/neushen-therapeutics-announces-poster-presentation-at-acs-fall.html 2026-01-12 daily 0.5 https://www.neushen.com/news/2023/neushen-therapeutics-hosted-gene-therapy-clinical-psychiatry-experts.html 2026-01-12 daily 0.5 https://www.neushen.com/news/2023/neushen-therapeutics-umass-chan-als-program-to-present-at-esgct.html 2026-01-12 daily 0.5 https://www.neushen.com/news/2023/neushen-therapeutics-announces-nmpa-cde-acceptance-of-ind-application-for-kcnq23-activator-ns-041.html 2026-01-12 daily 0.5 https://www.neushen.com/news/2024/neushen-therapeutics-announces-four-presentations-at-asgct-annual-meeting.html 2026-01-12 daily 0.5 https://www.neushen.com/news/2024/neushen-therapeutics-granted-nmpa-cde-ind-approval-for-kcnq23-activator-ns-041.html 2026-01-12 daily 0.5 https://www.neushen.com/news/2024/ns-136-m4-pam-first-in-human-trial.html 2026-01-12 daily 0.5 https://www.neushen.com/news/2025/neushen_therapeutics_to_present_at_neuroscience_2025.html 2026-01-07 daily 0.5 https://www.neushen.com/company/advisors/guangping-gao.html 2025-07-07 daily 0.5 https://www.neushen.com/company/leadership/mike-poole.html 2025-07-07 daily 0.5 https://www.neushen.com/company/advisors/mark-opler.html 2025-06-10 daily 0.5 https://www.neushen.com/company/advisors/lan-qin.html 2025-06-10 daily 0.5 https://www.neushen.com/company/advisors/larry-alphs.html 2025-06-10 daily 0.5 https://www.neushen.com/company/leadership/joan-huaqiong-shen.html 2025-06-10 daily 0.5 https://www.neushen.com/company/leadership/chao-zhang.html 2025-06-10 daily 0.5 https://www.neushen.com/careers/2025/02.html 2025-02-12 daily 0.5